Display options
Cite
Galindo-Ferreiro A, Sanchez-Tocino H, Diez-Montero C, et al. Characteristics and Recurrence of Primary Eyelid Basal Cell Carcinoma in Central Spain. J Curr Ophthalmol. 2020;32(2):183-188doi: 10.4103/JOCO.JOCO_28_20.
Galindo-Ferreiro, A., Sanchez-Tocino, H., Diez-Montero, C., Belani-Raju, M., García-Sanz, R., Diego-Alonso, M., Llorente-Gonzalez, I., Perez, P. C., Khandekar, R., & Schellini, S. (2020). Characteristics and Recurrence of Primary Eyelid Basal Cell Carcinoma in Central Spain. Journal of current ophthalmology, 32(2), 183-188. https://doi.org/10.4103/JOCO.JOCO_28_20
Galindo-Ferreiro, Alicia, et al. "Characteristics and Recurrence of Primary Eyelid Basal Cell Carcinoma in Central Spain." Journal of current ophthalmology vol. 32,2 (2020): 183-188. doi: https://doi.org/10.4103/JOCO.JOCO_28_20
Galindo-Ferreiro A, Sanchez-Tocino H, Diez-Montero C, Belani-Raju M, García-Sanz R, Diego-Alonso M, Llorente-Gonzalez I, Perez PC, Khandekar R, Schellini S. Characteristics and Recurrence of Primary Eyelid Basal Cell Carcinoma in Central Spain. J Curr Ophthalmol. 2020 Apr 30;32(2):183-188. doi: 10.4103/JOCO.JOCO_28_20. eCollection 2020. PMID: 32671303; PMCID: PMC7337017.
Copy Download .nbib Format: NLM
Share it on

J Curr Ophthalmol. 2020 Apr 30;32(2):183-188. doi: 10.4103/JOCO.JOCO_28_20. eCollection 2020.

Characteristics and Recurrence of Primary Eyelid Basal Cell Carcinoma in Central Spain.

Journal of current ophthalmology

Alicia Galindo-Ferreiro, Hortensia Sanchez-Tocino, Cecilia Diez-Montero, Minal Belani-Raju, Raquel García-Sanz, Miguel Diego-Alonso, Ines Llorente-Gonzalez, Patricia Callejo Perez, Rajiv Khandekar, Silvana Schellini

Affiliations

  1. Department of Ophthalmology, Rio Hortega University Hospital, Valladolid, Spain.
  2. Department of Pathology, Rio Hortega University Hospital, Valladolid, Spain.
  3. Research Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
  4. Department of Ophthalmology, Botucatu Medical University - UNESP, São Paulo, Brazil.

PMID: 32671303 PMCID: PMC7337017 DOI: 10.4103/JOCO.JOCO_28_20

Abstract

PURPOSE: To define the incidence, characteristics, and management of eyelid basal cell carcinoma (BCC) in Central Spain.

METHODS: This retrospective study investigates the characteristics and the outcome of eyelid BCC from 2000 to 2016 in a central region of Spain. Data were collected on demographics, skin phenotype, location of the eyelid lesion, clinical and histological diagnosis, surgery, commitment of surgical margins, and recurrence rate.

RESULTS: Primary eyelid BCC occurred in a mean of 20.6 lesions a year or 9.4/100,000 inhabitants/year. The mean age of BCC carriers was 69.4 ± 16.2 years, with no gender difference (

CONCLUSIONS: The frequency of occurrence of eyelid BCC is much less than the estimated crude incidence for skin tumors involving all areas of the body in the Spanish population. Eyelid BCC is more common in the seventh decade of life, with no predilection for gender. Nodular histological type is the most common. The recurrence rate is 5.6%, depending on site and affected margins, even though clear free margins also can present with recurrence.

Copyright: © 2020 Journal of Current Ophthalmology.

Keywords: Basal cell carcinoma; Eyelid tumors; Periocular; Spain

Conflict of interest statement

There are no conflicts of interest.

References

  1. Actas Dermosifiliogr. 2016 May;107(4):318-28 - PubMed
  2. Am J Dermatopathol. 2009 May;31(3):256-62 - PubMed
  3. Ocul Oncol Pathol. 2019 Apr;5(3):210-219 - PubMed
  4. Int J Environ Res Public Health. 2018 Sep 20;15(10): - PubMed
  5. ISRN Dermatol. 2012;2012:246542 - PubMed
  6. ANZ J Surg. 2002 Mar;72(3):219-21 - PubMed
  7. Br J Dermatol. 2009 Mar;160(3):573-80 - PubMed
  8. Eur J Dermatol. 2017 Aug 1;27(4):363-368 - PubMed
  9. J Laryngol Otol. 2016 May;130(S2):S125-S132 - PubMed
  10. Oral Maxillofac Surg. 2013 Jun;17(2):115-8 - PubMed
  11. Korean J Ophthalmol. 2019 Aug;33(4):366-370 - PubMed
  12. An Bras Dermatol. 2010 Nov-Dec;85(6):872-7 - PubMed
  13. Br J Dermatol. 2012 May;166(5):1069-80 - PubMed
  14. J Ayub Med Coll Abbottabad. 2012 Jul-Dec;24(3-4):141-3 - PubMed
  15. J Surg Oncol. 1985 Jan;28(1):72-4 - PubMed
  16. N Engl J Med. 1965 Oct 21;273(17):923-4 - PubMed
  17. Br J Ophthalmol. 2005 Aug;89(8):992-4 - PubMed
  18. Acta Chir Plast. 2006;48(3):89-92 - PubMed
  19. Br J Dermatol. 2004 Sep;151(3):623-6 - PubMed
  20. Plast Reconstr Surg. 1967 Jun;39(6):619-24 - PubMed
  21. Lancet. 2010 Feb 20;375(9715):673-85 - PubMed
  22. Ophthalmology. 2004 Apr;111(4):631-6 - PubMed
  23. Int Ophthalmol Clin. 2009 Fall;49(4):97-110 - PubMed
  24. Plast Reconstr Surg. 1982 Jan;69(1):110-6 - PubMed
  25. Ophthalmology. 2009 Apr;116(4):802-6 - PubMed
  26. J Plast Reconstr Aesthet Surg. 2007;60(1):41-7 - PubMed
  27. ISRN Ophthalmol. 2012 Apr 24;2012:354829 - PubMed
  28. Acta Derm Venereol. 2004;84(1):44-7 - PubMed
  29. Br J Plast Surg. 2000 Oct;53(7):563-6 - PubMed
  30. Eye (Lond). 2019 Oct;33(10):1534-1539 - PubMed
  31. An Bras Dermatol. 2017 Jan-Feb;92(1):58-62 - PubMed
  32. Int J Cancer. 2010 Nov 1;127(9):2190-8 - PubMed
  33. J Plast Reconstr Aesthet Surg. 2016 May;69(5):652-6 - PubMed
  34. Br J Dermatol. 2011 Apr;164(4):822-9 - PubMed
  35. Eye (Lond). 2013 Jan;27(1):78-83 - PubMed
  36. Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):96-102 - PubMed
  37. Middle East Afr J Ophthalmol. 2013 Jul-Sep;20(3):187-92 - PubMed
  38. Semin Ophthalmol. 2016;31(4):317-24 - PubMed

Publication Types